Consensus Luye Pharma Group Ltd.

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:08:16 02/05/2024 BST			5-day change	1st Jan Change
3.02 ^HKD	+9.03%		+13.96%	-19.03%

03-27	Luye Pharma Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-07	Luye Pharma Group Announces the Launch of Its Innovative Drug Zepzelca® (Lurbinectedin) for the Treatment of SCLC in Both Hong Kong and Macao	CI

d51e34f19e.iQBEsR7_mSV-rgyhEw8MsXloX--MuJEq4H4iBqWlZEo.wzMg_UyZ4VMU5mnNdW5n4RMLKp2h6ad_qy5KdMDPADzhd3eIUqj8EhOYTQ~90ca3a75d22ae5726d8766271ba78036

07/06/22

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

2.797 CNY

Average target price

2.785 CNY

Spread / Average Target

-0.43%

High Price Target

3.65 CNY

Spread / Highest target

+30.51%

Low Price Target

2.221 CNY

Spread / Lowest Target

-20.59%

Trading Rating

Investor Rating

ESG Refinitiv

B-